MiRNA-374b-5p and miRNA-106a-5p are related to inflammatory bowel disease via regulating IL-10 and STAT3 signaling pathways

Table 1 Baseline information of IBD patients and healthy controls

Variable	Healthy controls	CD (A/R)	UC (A/R)	P value
Number of patients	30	15 (9/6)	34 (22/12)
Age (years)	38.14 ± 7.55	37.24 ± 6.87	38.61 ± 8.04	> 0.05
Gender
Male	16	8 (5/3)	15 (10/5)	> 0.05
Female	14	7 (4/3)	19 (12/7)
Disease duration (months)		39.25 ± 8.43	41.25 ± 8.67	> 0.05
Mayo Scores (UC)			7.79 ± 1.51/1.12 ± 0.64
CD activity index (CD)		170 ± 30/70 ± 11
Disease extent (UC)
E1			8 (6/2)
E2			16 (10/6)
E3			10 (5/5)
Disease location (CD)
L1		4 (2/2)
L2		7 (4/3)
L3		4 (3/1)
L4		0

CD Crohn’s disease, L1 Terminal ileum, L2 Colon, L3 Ileocolon, L4 Upper gastrointestinal tract, A/R Active/Remission, UC Ulcerative colitis, E1 Proctitis, E2 Left-sided colitis, E3 Extensive colitis

ISSN: 1471-230X